Co-Infection Associated with SARS-CoV-2 and Their Management

Figures & data

Table 1. Estimated data of post-COVID-19 complications.

Countries	Cases of post COVID-19 complications				Ref.
	Mucormycosis	Candidiasis	MIS-C	Happy hypoxia
India	>40,854	>9000	>3000	>1500	[65–68]
USA	>100	–	–	–	[66,69]
UK	>500	–	–	–	[66,70]
Mexico	–	–	–	>500	[71]
Japan	–	–	–	>100	[72]
Canada	>300	–	–	–	[65]
Australia	>100	–	–	–	[73]

Figure 1. Methodology for inclusion and exclusion of the work.

Figure 2. Mechanistic representation of cardiovascular complications that may occur during the post-COVID-19 recovery phase.

Figure was originally created with biorender.com

Figure 3. SARS-CoV-2-induced pneumonia causes chronic hypoxemic respiratory failure that is attributed to acute respiratory distress syndrome.

Figure was originally created with biorender.com

ARDS: Acute respiratory distress syndrome.

Figure 4. A mechanistic overview of SARS-CoV-2-induced platelet activation that leads to secondary complications such as antiphospholipid syndrome and blood clots.

Figure was originally created with biorender.com

MeghnaSen. Black Fungus: these 2 states account for nearly 42% of India's 28,252 mucormycosis cases. Livemint.8 (2021).

 Google Scholar

ShawahnaR , JaradatNA. Ethnopharmacological survey of medicinal plants used by patients with psoriasis in the West Bank of Palestine. BMC Complement Altern Med.17, 1–9 (2017).

 PubMed Web of Science ®Google Scholar

GargD , MuthuV , SehgalISet al.Coronavirus Disease (COVID-19) associated mucormycosis (CAM): Case Report and Systematic Review of literature. Mycopathologia186, 289–298 (2021).

 PubMed Web of Science ®Google Scholar

WidysantoA , WahyuniTD , SimanjuntakLHet al.Happy hypoxia in critical COVID-19 patient: a case report in Tangerang, Indonesia. Physiol Rep.8, 1–5 (2020).

 Web of Science ®Google Scholar

JounieauxV , RodensteinDO , MahjoubY. On happy hypoxia and on sadly ignored “acute vascular distress syndrome” in patients with COVID-19. Am. J. Respir. Crit. Care Med.202, 1598–1599 (2020).

 PubMed Web of Science ®Google Scholar

SinghAK , SinghR , JoshiSRet al.Mucormycosis in COVID-19: a Systematic Review of cases reported worldwide and in India. Diabetes Metab Syndr Clin Res Rev (2021

 Web of Science ®Google Scholar

HussainS , RiadA , SinghAet al.Global prevalence of COVID-19-associated mucormycosis (CAM): living Systematic Review and Meta-Analysis. J. Fungi (Basel, Switzerland)7 (2021).

 Google Scholar